Search results
CVS Stock Is Dirt Cheap. That Doesn’t Make It a Buy.
Barrons.com· 2 days agoFEATURE Shares of CVS Health just went on sale. But like Valentine’s candy in March, just because something is cheap, that doesn’t make it a good buy....
A year of Medicaid ‘unwinding’ cuts 600,000, but renews nearly 2 million on Arizona’s rolls
Arizona Mirror via Yahoo News· 4 days agoOne year after restarting the pre-pandemic review process for enrollment in Medicaid and the...
These Jobs Offer Health Insurance After You Retire
AOL· 5 days agoIf you’re aiming for early retirement before age 65, it’s crucial to explore your healthcare choices. Some employers extend healthcare benefits to those...
Are Consumer Driven Health Plans the right FEHB plan for you?
Government Executive· 2 days agoConsumer Driven Health Plans or CDHPs have been around for a while, but we still get lots of...
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 1 day agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...
Q1 2024 CNO Financial Group Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoFirst time customers who are new to Medicare are most in need of the service and expertise provided...
3 common mistakes that could damage your retirement nest egg — and how to avoid them
AOL· 5 days agoThere are plenty of ways to save for retirement and pad your nest egg for those golden years. From 401(k) plans and Roth IRAs to health savings accounts and delayed Social Security benefits, ...
Please reconsider support of United Healthcare
AARP· 3 days agoI must register my feedback on your long standing promotion of United Healthcare's Med Advantage plans. I work in healthcare, specifically rehab therapy. I have seen first hand the devastating ...
The 10 Trends and Legal Challenges We Are Tracking Throughout 2024
The National Law Review· 3 days agoFollowing the hearing, some senators called for assisted living facilities to be brought under the...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 2 days agoHe highlighted the broad population studied in the CABINET trial, which should make cabozantinib user-friendly and widely applicable across various subtypes of NET, enhancing its market adoption ...